Serum pyridoxine levels in HIV-positive patients and its association with tuberculosis and neuropsychiatric manifestations

M. Prabha Adhikari, Sahana Acharya, John Ramapuram, Satish Rao, Kiran Vadapalli, Mukta Chowta, Sheetal Ullal

Research output: Contribution to journalArticle

Abstract

Background: Studies have shown the prevalence of micronutrient insufficiency in HIV patients. Decreased plasma levels of pyridoxine, Vitamins B12, A, and E, and zinc have been correlated with significant alterations in immune response and cognitive functions. Serum pyridoxine levels in different subgroup of HIV patients are not well studied. Objective: To study the proportion of pyridoxine deficiency in different subgroups of HIV-positive patients (HIV with tuberculosis - Group I, HIV with neuropsychiatric manifestations - Group II, and HIV-positive patients without neuropsychiatric symptoms or tuberculosis - Group III) and the comparison of mini mental state examination (MMSE) score, Hamilton depression rating scale (HAM-D), and Hamilton anxiety rating scale (HAM-A) in them. Methodology: One hundred and fifty HIV patients were divided into three groups. MMSE, HAM-D, HAM-A, hemoglobin levels, pyridoxine levels, waist-hip ratio, and body mass index were noted. Results: The proportion of patients with pyridoxine deficiency was 18.8% in Group I and 28.3% in Group II. The percentage of pyridoxine deficiency between Group II and Group III significantly differ (P = 0.048). Patients in Group II showed an association with abnormal neuropsychiatric assessment using MMSE/HAM-D/HAM-A (χ2 = 7.843; P = 0.005). There was a significant correlation between CD4 count and pyridoxine in Group I (r = 0.391, P = 0.006) only. Interpretation and Conclusions: Increased proportion of pyridoxine deficiency is seen in individuals with HIV. Proportion of pyridoxine deficiency is also higher in HIV patients with neuropsychiatric manifestations. HIV patients with neuropsychiatric symptoms and tuberculosis have a low CD4 count and pyridoxine levels as compared to HIV-positive patients without neuropsychiatric symptoms or tuberculosis.

Original languageEnglish
Pages (from-to)157-161
Number of pages5
JournalInternational Journal of Nutrition, Pharmacology, Neurological Diseases
Volume6
Issue number4
DOIs
Publication statusPublished - 01-10-2016

Fingerprint

Pyridoxine
Tuberculosis
HIV
Vitamin B 6 Deficiency
Serum
CD4 Lymphocyte Count
Waist-Hip Ratio
Micronutrients
Vitamin B 12
Vitamin E
Cognition
Zinc
Hemoglobins
Body Mass Index
Anxiety
Depression

All Science Journal Classification (ASJC) codes

  • Nutrition and Dietetics
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

@article{c9ce4a68713e4848a76f572f18b954ec,
title = "Serum pyridoxine levels in HIV-positive patients and its association with tuberculosis and neuropsychiatric manifestations",
abstract = "Background: Studies have shown the prevalence of micronutrient insufficiency in HIV patients. Decreased plasma levels of pyridoxine, Vitamins B12, A, and E, and zinc have been correlated with significant alterations in immune response and cognitive functions. Serum pyridoxine levels in different subgroup of HIV patients are not well studied. Objective: To study the proportion of pyridoxine deficiency in different subgroups of HIV-positive patients (HIV with tuberculosis - Group I, HIV with neuropsychiatric manifestations - Group II, and HIV-positive patients without neuropsychiatric symptoms or tuberculosis - Group III) and the comparison of mini mental state examination (MMSE) score, Hamilton depression rating scale (HAM-D), and Hamilton anxiety rating scale (HAM-A) in them. Methodology: One hundred and fifty HIV patients were divided into three groups. MMSE, HAM-D, HAM-A, hemoglobin levels, pyridoxine levels, waist-hip ratio, and body mass index were noted. Results: The proportion of patients with pyridoxine deficiency was 18.8{\%} in Group I and 28.3{\%} in Group II. The percentage of pyridoxine deficiency between Group II and Group III significantly differ (P = 0.048). Patients in Group II showed an association with abnormal neuropsychiatric assessment using MMSE/HAM-D/HAM-A (χ2 = 7.843; P = 0.005). There was a significant correlation between CD4 count and pyridoxine in Group I (r = 0.391, P = 0.006) only. Interpretation and Conclusions: Increased proportion of pyridoxine deficiency is seen in individuals with HIV. Proportion of pyridoxine deficiency is also higher in HIV patients with neuropsychiatric manifestations. HIV patients with neuropsychiatric symptoms and tuberculosis have a low CD4 count and pyridoxine levels as compared to HIV-positive patients without neuropsychiatric symptoms or tuberculosis.",
author = "{Prabha Adhikari}, M. and Sahana Acharya and John Ramapuram and Satish Rao and Kiran Vadapalli and Mukta Chowta and Sheetal Ullal",
year = "2016",
month = "10",
day = "1",
doi = "10.4103/2231-0738.191678",
language = "English",
volume = "6",
pages = "157--161",
journal = "International Journal of Nutrition, Pharmacology, Neurological Diseases",
issn = "2231-0738",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "4",

}

TY - JOUR

T1 - Serum pyridoxine levels in HIV-positive patients and its association with tuberculosis and neuropsychiatric manifestations

AU - Prabha Adhikari, M.

AU - Acharya, Sahana

AU - Ramapuram, John

AU - Rao, Satish

AU - Vadapalli, Kiran

AU - Chowta, Mukta

AU - Ullal, Sheetal

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background: Studies have shown the prevalence of micronutrient insufficiency in HIV patients. Decreased plasma levels of pyridoxine, Vitamins B12, A, and E, and zinc have been correlated with significant alterations in immune response and cognitive functions. Serum pyridoxine levels in different subgroup of HIV patients are not well studied. Objective: To study the proportion of pyridoxine deficiency in different subgroups of HIV-positive patients (HIV with tuberculosis - Group I, HIV with neuropsychiatric manifestations - Group II, and HIV-positive patients without neuropsychiatric symptoms or tuberculosis - Group III) and the comparison of mini mental state examination (MMSE) score, Hamilton depression rating scale (HAM-D), and Hamilton anxiety rating scale (HAM-A) in them. Methodology: One hundred and fifty HIV patients were divided into three groups. MMSE, HAM-D, HAM-A, hemoglobin levels, pyridoxine levels, waist-hip ratio, and body mass index were noted. Results: The proportion of patients with pyridoxine deficiency was 18.8% in Group I and 28.3% in Group II. The percentage of pyridoxine deficiency between Group II and Group III significantly differ (P = 0.048). Patients in Group II showed an association with abnormal neuropsychiatric assessment using MMSE/HAM-D/HAM-A (χ2 = 7.843; P = 0.005). There was a significant correlation between CD4 count and pyridoxine in Group I (r = 0.391, P = 0.006) only. Interpretation and Conclusions: Increased proportion of pyridoxine deficiency is seen in individuals with HIV. Proportion of pyridoxine deficiency is also higher in HIV patients with neuropsychiatric manifestations. HIV patients with neuropsychiatric symptoms and tuberculosis have a low CD4 count and pyridoxine levels as compared to HIV-positive patients without neuropsychiatric symptoms or tuberculosis.

AB - Background: Studies have shown the prevalence of micronutrient insufficiency in HIV patients. Decreased plasma levels of pyridoxine, Vitamins B12, A, and E, and zinc have been correlated with significant alterations in immune response and cognitive functions. Serum pyridoxine levels in different subgroup of HIV patients are not well studied. Objective: To study the proportion of pyridoxine deficiency in different subgroups of HIV-positive patients (HIV with tuberculosis - Group I, HIV with neuropsychiatric manifestations - Group II, and HIV-positive patients without neuropsychiatric symptoms or tuberculosis - Group III) and the comparison of mini mental state examination (MMSE) score, Hamilton depression rating scale (HAM-D), and Hamilton anxiety rating scale (HAM-A) in them. Methodology: One hundred and fifty HIV patients were divided into three groups. MMSE, HAM-D, HAM-A, hemoglobin levels, pyridoxine levels, waist-hip ratio, and body mass index were noted. Results: The proportion of patients with pyridoxine deficiency was 18.8% in Group I and 28.3% in Group II. The percentage of pyridoxine deficiency between Group II and Group III significantly differ (P = 0.048). Patients in Group II showed an association with abnormal neuropsychiatric assessment using MMSE/HAM-D/HAM-A (χ2 = 7.843; P = 0.005). There was a significant correlation between CD4 count and pyridoxine in Group I (r = 0.391, P = 0.006) only. Interpretation and Conclusions: Increased proportion of pyridoxine deficiency is seen in individuals with HIV. Proportion of pyridoxine deficiency is also higher in HIV patients with neuropsychiatric manifestations. HIV patients with neuropsychiatric symptoms and tuberculosis have a low CD4 count and pyridoxine levels as compared to HIV-positive patients without neuropsychiatric symptoms or tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=84993971795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993971795&partnerID=8YFLogxK

U2 - 10.4103/2231-0738.191678

DO - 10.4103/2231-0738.191678

M3 - Article

VL - 6

SP - 157

EP - 161

JO - International Journal of Nutrition, Pharmacology, Neurological Diseases

JF - International Journal of Nutrition, Pharmacology, Neurological Diseases

SN - 2231-0738

IS - 4

ER -